Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA asks NDMA for anticaries biological testing information.

This article was originally published in The Tan Sheet

Executive Summary

ANTICARIES BIOLOGICAL TESTING INFORMATION REQUESTED BY FDA in a May 24 letter to the Nonprescription Drug Manufacturers Association. Responding to an April 17 citizen petition submitted on behalf of an NDMA/Cosmetic, Toiletry and Fragrance Association joint task force, the letter states that the agency will not make a decision on whether to extend the effective date of the OTC anticaries final monograph biological testing requirements by 12 months (to Oct. 7, 1997) until the information has been received.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel